Size: 2478
Comment:
|
Size: 3082
Comment:
|
Deletions are marked like this. | Additions are marked like this. |
Line 36: | Line 36: |
* | |
Line 53: | Line 53: |
* The original t1 set will also be used as one of the final sequences. * Field of view for DESS images was smaller than other sequences. * All the future imaging sequence reports will be created using the imaging sequence template in the OAI study (reporting all the sequence information necessary. e.g field of view, resolution etc). * t1 (good for ligaments) and 3D DESS (good for cartilage and meniscus) will be used as primary conditions and any other supporting sequences will be added as secondary conditions. * Imaging page will be updated accordingly. * |
Recurring Meeting of Cleveland Clinic Core Team
Date: Nov 26, 2013
Time: 10:30 AM EST
Means: In person meeting
Attendees:
- Ahmet Erdemir
- Jason Halloran
- Craig Bennetts
- Snehal Chokhandre
- Robb Colbrunn
- Tara Bonner
Agenda:
- Discuss tasks progress.
- Discuss specimen transportation device design and options.
- Compare quotes from other vendors and finalize tissue testing equipment purchase.
- Decide tasks for the next meeting.
- Other
Immediate action items:
Robb
- Add information regarding data files and data structures in joint specifications.
Snehal
- Add more 3D DESS images to the imaging specifications page and ask Shannon at UH to program the 2D MESE sequence off line before the next imaging test session.
Notes:
- Discuss task progress
- Immediate action items were discussed.
- Feature specification development is on going. CCF team summarized the needs and provided test problems.In situ strains feature development is in progress and the supplied test problem is being used. The connector feature need was summarised and test problem will be provided.
- Craig updated the cloud computing prototype and the CCF team met with the Stanford team. The gateway design and implementation was discussed and will be worked on in the following months.
- Snehal obtained quotes from 4 vendors for the tissue testing machine and did cost and feature comparison.
- Robb has been communicating with the Biomomentum engineers and trying to reach an agreement for machine feature and budget needs.
- Imaging specifications
- Snehal updated sample images from the test session at UH in Nov 14th.
- The t2 proton density sequence programmed by Chris to get better ligament images did not provide sufficient information.
- Snehal will add more images for all the sequence types.
The second sequence was programmed to match the 3D DESS sequence from the study by Peterfy et al http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048821/.
- Cartilage and meniscus can be seen very clearly in these images and the team decided to use the current sequence setting for one of the final imaging sequences.
- Snehal will add images from this dataset showing ligaments.
- The original t1 set will also be used as one of the final sequences.
- Field of view for DESS images was smaller than other sequences.
- All the future imaging sequence reports will be created using the imaging sequence template in the OAI study (reporting all the sequence information necessary. e.g field of view, resolution etc).
- t1 (good for ligaments) and 3D DESS (good for cartilage and meniscus) will be used as primary conditions and any other supporting sequences will be added as secondary conditions.
- Imaging page will be updated accordingly.
- Immediate action items were discussed.